Insider filing · MIRM
Michael G Grey
Director
profile →
Mirum Pharmaceuticals, Inc.
MIRM · Healthcare · 60 filings in 24 months
ticker →
Michael G Grey sold $3.9M of Mirum Pharmaceuticals (MIRM)
Executed Dec 19 2025, disclosed Dec 23 2025, 4 days later.
Value, as filed
$3.9M
50,000 sh × $78.00
Executed
Dec 19 2025
the trade date, as filed
Disclosed
Dec 23 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MGMichael G Grey (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $3.9M of MIRM (50,000 sh × $78.00, as filed), executed Dec 19 2025.
The name
MIRMHealthcare · Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitat…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael G Grey in MIRM
MIRMSALE
Mirum Pharmaceuticals, Inc.
$3.7M50,000 sh × $74.00
Exec Dec 1 2025
Filed Dec 2 2025 · 5:30 PM ET MIRMSALE Mirum Pharmaceuticals, Inc. $3.5M
50,000 sh × $70.00
Exec Nov 21 2025
Filed Nov 25 2025 · 5:30 PM ET